RxDoctor Payments Data

Michael Pistiner

Allergy & Immunology · Boston, MANPI 1851351662

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,080 of the $35,788 with a category attached, or 64.5%. 5 manufacturers reported payments, led by Kaleo, Inc. at 39.8% of the total. 2025 is the largest year on record at $12,800, more than ten times the $34 reported in 2019.

$35,788in general payments, 2019–2025

Across 30 payments — averaging $1192.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kaleo, Inc.$14K
  • Aimmune Therapeutics, Inc.$11K
  • Novartis$10K
  • Aquestive Therapeutics, Inc.$277
  • Boston Scientific$23
$507,959in research payments, 2019–2025

Across 17 payments — averaging $29,880 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kaleo, Inc.$508K

What the payments were for

  • Consulting fees$23,08064%
  • Speaking & faculty fees$10,90030%
  • Travel & lodging$8882%
  • Food & beverage$9203%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,788 in reported general payments places this provider in the 85th percentile of 114 allergy & immunology providers in Massachusetts.

See all allergy & immunology providers in Massachusetts

Other allergy & immunology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →